R.W. Brimblecombe - Concepedia

Author

R.W. Brimblecombe

Also Known As

R BRIMBLECOMBE, R Brimblecombe, R W BRIMBLECOMBE, R W Brimblecombe, R. Brimblecombe, R. W. BRIMBLECOMBE, R. W. Brimblecombe, R.W Brimblecombe, R.W. Brimblecombe, Roger Brimblecombe

Publications

1.9K

Citations

H-Index

Concepts

All Affiliations

Ministry of Defence Defence Science and Technology Laboratory Salisbury University Hertfordshire Community NHS Trust

About

R.W. Brimblecombe is an author at Ministry of Defence specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	28	1.3K
2	Social Sciences	8	8	165
3	Natural Sciences	7	7	107
4	Health Sciences	4	4	130
5	Public Health	3	3	56

R.W. Brimblecombe

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
Cimetidine—A Non-Thiourea H<sub>2</sub>-Receptor Antagonist R.W. Brimblecombe, W. A. M. Duncan, G. J. DURANT, Journal of International Medical Research Molecular PharmacologyPharmacological StudyMedicine-Receptor AntagonistMechanism Of Action	1975	450
Characterization and development of cimetidine as a histamine H2-receptor antagonist R.W. Brimblecombe, W. A. M. Duncan, G. J. DURANT, Gastroenterology AllergyMedicineMechanism Of ActionPharmacological AgentHistamine H2-receptor Antagonist	1978	202
INTRAGASTRIC ACIDITY, BACTERIA, NITRITE, AND N-NITROSO COMPOUNDS BEFORE, DURING, AND AFTER CIMETIDINE TREATMENT G J Milton-Thompson, Z. Ahmet, N. F. Lightfoot, The Lancet Intragastric AcidityReactive Nitrogen SpecieMedicineToxicologyMicrobiology	1982	102
THE CENTRAL AND PERIPHERAL ACTIVITY OF ACETYLENIC AMINES RELATED TO OXOTREMORINE A. Bebbington, R.W. Brimblecombe, Derek Shakeshaft British Journal of Pharmacology and Chemotherapy	1966	67
Effects of psychotropic drugs on open-field behaviour in rats R.W. Brimblecombe Psychopharmacology Psychoactive DrugOpen-field BehaviourBehavioral NeuroscienceAddictionBehavioural Pharmacology	1963	55
Evaluation of the nitrosamine hypothesis of gastric carcinogenesis in precancerous conditions. Callum Hall, D. Darkin, R.W. Brimblecombe, Gut NutritionGastroenterologyPathologyPrecancerous ConditionsDigestive Tract	1986	46
Proceedings: The pharmacology of cimetidine, a new histamine H2-receptor antagonist. R.W. Brimblecombe, W. A. M. Duncan, G. J. DURANT, PubMed Central Molecular PharmacologyPharmacological StudyMedicinePharmacological AgentClinical Pharmacology	1975	41
The protective actions of some anticholinergic drugs in sarin poisoning R.W. Brimblecombe, D. M. GREEN, JUNE A. STRATTON, British Journal of Pharmacology PharmacotherapyExperimental PharmacologyAdverse Drug ReactionDrug ResistanceMolecular Pharmacology	1970	40
Intragastric N-nitrosation is unlikely to be responsible for gastric carcinoma developing after operations for duodenal ulcer. M R B Keighley, Denise Youngs, V Poxon, Gut Control GroupSurgical ProceduresGastrointestinal OncologyGastroenterologyPathology	1984	37
Mesalazine: A Global Safety Evaluation R.W. Brimblecombe Scandinavian Journal of Gastroenterology	1990	35

Page 1